COVID-19: For information related to COVID-19 (formerly referred to as “novel coronavirus"), visit

VCU Massey Cancer Center


MicroRNA study funded by National Institute of Justice

DNA for family tree risk blog post [View Image]

‌A collaborative team of cancer and forensic science researchers at Virginia Commonwealth University (VCU) and VCU Massey Cancer Center were awarded a two-year, $310,000 grant from the Office of Justice Programs, housed within the National Institute of Justice (NIJ), to study microRNAs. MicroRNAs are a recently discovered class of RNAs that play key roles in the regulation of gene expression.

Most people are familiar with DNA, the molecule found in our bodies that encodes the genetic instructions and is often referred to as one of the building blocks, or blueprint, of the body. And if you’ve watched a crime show, you know that DNA is an important part of forensic science that helps to identify suspects.

What is not so familiar are RNAs, which are working “copies” of DNA found in different cells, including bodily fluids. Also considered one of the building blocks of the body, RNA is typically found in a single-stranded form in cells, whereas DNA is usually in a double-stranded form.

The study’s co-principal investigator, Zendra Zehner, Ph.D., researcher in the Cancer Molecular Genetics program at VCU Massey Cancer Center and professor in the Department of Biochemistry and Molecular Biology at VCU School of Medicine, is hoping to find new biomarkers for prostate cancer through microRNAs.

“Approximately 1,600 microRNAs have been identified so far, and we suspect there are more that we hope to find through deep sequencing, a technique that converts microRNAs to cDNAs and then determines the sequence of every microRNA in the sample using classic DNA sequencing methods. It is a new and novel approach,” said Zehner. “In my research, I am looking at the diagnostic probabilities for prostate cancer by studying microRNAs to find an indicator of cancer. The goal is to develop a new and improved prostate cancer test by using appropriate bodily fluids to check for microRNAs denoting cancer. An easier test will mean better screening measures and the opportunity to find and start treating prostate cancer earlier, thus saving lives.”

The researchers are also using deep sequencing to identify and characterize microRNAs in forensically important biological fluids. This molecular identification of bodily fluids represents a new technique that supplements DNA analysis in forensic cases.

“Identifying any bodily fluid at a molecular level would be highly advantageous for forensic evidence,” said Sarah Seashols, M.S., the study’s other co-principal investigator and forensic molecular biology instructor in the VCU Department of Forensic Science.

The NIJ grant was highly competitive, with only 11 grants awarded out of more than 90 applications from across the nation.

“I believe we attained this award due, in part, to the combination of our strengths in forensic science and basic/cancer research,” said Zehner. “This study is a great illustration of the important interdisciplinary research and collaboration taking place at VCU.”

By: Francis Dumenci, Alaina Farrish and Jenny Owen

Written by: Alaina Schneider

Posted on: April 19, 2013

Category: Research

View graphic versionView graphic versionView graphic version